Not applicableEnded earlyNCT01271959What this trial is testingChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry StudyWho this might be right forSolid Organ Tumors Precision Therapeutics 167
Testing effectiveness (Phase 2)Looking for participantsNCT05579366What this trial is testingRinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)Who this might be right forHigh Grade Epithelial Ovarian CancerHigh Grade Serous Ovarian CancerPrimary Peritoneal Carcinoma+12 more Genmab 764
Testing effectiveness (Phase 2)Study completedNCT02860286What this trial is testingStudy of the EZH2 Inhibitor Tazemetostat in Malignant MesotheliomaWho this might be right forMesotheliomaBAP1 Loss of Function Epizyme, Inc. 74
Testing effectiveness (Phase 2)Study completedNCT00024076What this trial is testingRadiofrequency Ablation in Treating Patients With Refractory or Advanced Lung CancerWho this might be right forLung CancerMalignant MesotheliomaMetastatic Cancer+1 more Jonsson Comprehensive Cancer Center 30
Early research (Phase 1)Study completedNCT02071862What this trial is testingStudy of the Glutaminase Inhibitor CB-839 in Solid TumorsWho this might be right forSolid TumorsTriple-Negative Breast CancerNon Small Cell Lung Cancer+7 more Calithera Biosciences, Inc 210
Early research (Phase 1)Study completedNCT02485119What this trial is testingPhase I Dose Escalation Study of BAY94-9343 Given by Intravenous Infusion Every 3 Weeks in Japanese Subjects With Advanced MalignanciesWho this might be right forNeoplasms Bayer 12
Early research (Phase 1)Ended earlyNCT03420963What this trial is testingDonor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid TumorsWho this might be right forRecurrent Cutaneous MelanomaRecurrent Lip and Oral Cavity CarcinomaRecurrent Malignant Endocrine Neoplasm+25 more M.D. Anderson Cancer Center 12
Very early researchEnded earlyNCT04213794What this trial is testingHeated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric PatientsWho this might be right forMalignant Abdominal NeoplasmMalignant Pelvic NeoplasmRecurrent Colon Carcinoma+24 more Mayo Clinic 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT02535312What this trial is testingMethoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or CarboplatinWho this might be right forAdvanced Malignant Solid NeoplasmAdvanced Peritoneal Malignant MesotheliomaAdvanced Pleural Malignant Mesothelioma+4 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00634205What this trial is testingPhase II Study of Valproate and Doxorubicin in Malignant MesotheliomaWho this might be right forMalignant Mesothelioma European Lung Cancer Working Party 45
Not applicableEnded earlyNCT00904514What this trial is testingStudy of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical TrialWho this might be right forCancer National Institutes of Health Clinical Center (CC) 241
Early research (Phase 1)Study completedNCT04430842What this trial is testingDose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072SWho this might be right forAstrocytomaBrain CancerBrain Metastases+20 more Quadriga Biosciences, Inc. 15
Testing effectiveness (Phase 2)UnknownNCT00551252What this trial is testingA Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractory, Malignant MesotheliomaWho this might be right forMesothelioma Gruppo Italiano MEsotelioma 56
Early research (Phase 1)UnknownNCT02580747What this trial is testingTreatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-mesoWho this might be right forMalignant MesotheliomaPancreatic CancerOvarian Tumor+3 more Chinese PLA General Hospital 20
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT03538028What this trial is testingA Safety and Tolerability Study of INCAGN02385 in Select Advanced MalignanciesWho this might be right forCervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more Incyte Biosciences International Sàrl 22
Testing effectiveness (Phase 2)Study completedNCT05795595What this trial is testingA Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid TumorsWho this might be right forClear Cell Renal Cell CarcinomaCervical CarcinomaEsophageal Carcinoma+2 more CRISPR Therapeutics AG 19
Testing effectiveness (Phase 2)Looking for participantsNCT07510815What this trial is testingDual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal MesotheliomaWho this might be right forMalignant Pleural Mesotheliomas Beijing Biotech 36
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06416930What this trial is testingStudy of Cadonilimab Combined With Chemotherapy in Recurrent / Refractory Pleural MesotheliomaWho this might be right forPleural Mesothelioma Cancer Institute and Hospital, Chinese Academy of Medical Sciences 59